Pharus Diagnostics develops pancancer detection tests using enhanced RNA technology integrated with diverse omics data for early screening. Their proprietary ML/AI platform analyzes this complex data to generate actionable insights, improving the accuracy of clinical decisions. This approach enables earlier cancer detection, supporting proactive health management and intervention.
Funding
$11M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current cancer detection methods often identify the disease at later stages, reducing treatment options and negatively impacting patient outcomes. Traditional screening processes can be invasive, expensive, and may not be easily integrated into routine health checkups.
Solution
The startup is developing liquid biopsy tests for early cancer detection using a single blood draw. Their approach leverages enhanced RNA-based genetic testing combined with diverse omics data integration to improve the accuracy of early detection. By applying proprietary machine learning (ML) and artificial intelligence (AI) technologies to the complex data generated, the platform aims to provide actionable insights for clinical decisions. The goal is to enable timely health management and potentially improve patient outcomes by identifying cancer at its earliest, most treatable stages.
Target Audience
The primary target audience includes individuals seeking proactive health monitoring, healthcare providers looking to improve early cancer detection rates, and clinical researchers focused on advancing cancer diagnostics.
Features
- Enhanced RNA-based technology for precise cancer screening.
- Integration of diverse omics data to achieve pancancer detection in a single analysis.
- Proprietary ML/AI technology to extract insights from complex data.
- Non-invasive liquid biopsy approach using a single blood draw.
- Easily adaptable testing process for integration into existing health checkup protocols.